Corcept Therapeutics is a pioneering biotechnology company dedicated to unlocking the potential of cortisol modulation. With over 25 years of expertise, they have developed more than 1,000 selective cortisol modulators and secured FDA approval for the first treatment for hypercortisolism (Cushing’s syndrome). The company continues to drive innovation across endocrinology, oncology, metabolism, and neurology through ongoing research and development.
Corcept is a research and development company focused on cortisol modulators and metabolic diseases. They have achieved FDA approval for Korlym and are actively developing relacorilant and miricorilant for endogenous hypercortisolism and MASH. The Associate Medical Director/Medical Director will lead clinical development, provide scientific oversight, and collaborate with clinical teams and external contacts.
Corcept Therapeutics is a pioneering biotechnology company dedicated to unlocking the potential of cortisol modulation. With over 25 years of expertise, they have developed more than 1,000 selective cortisol modulators and secured FDA approval for the first treatment for hypercortisolism (Cushing’s syndrome). The company continues to drive innovation across endocrinology, oncology, metabolism, and neurology through ongoing research and development.
BioMarin Pharmaceutical Inc.